Terms: = Skin cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Treatment
15 results:
1. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
Kovács SA; Fekete JT; Győrffy B
Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
[TBL] [Abstract] [Full Text] [Related]
2. Radiation-response in primary fibroblasts of long-term survivors of childhood cancer with and without second primary neoplasms: the KiKme study.
Grandt CL; Brackmann LK; Poplawski A; Schwarz H; Hummel-Bartenschlager W; Hankeln T; Kraemer C; Marini F; Zahnreich S; Schmitt I; Drees P; Mirsch J; Grabow D; Schmidberger H; Binder H; Hess M; Galetzka D; Marron M
Mol Med; 2022 Sep; 28(1):105. PubMed ID: 36068491
[TBL] [Abstract] [Full Text] [Related]
3. Mismatch repair protein loss in cutaneous head and neck squamous cell carcinoma.
Vasan K; Anand S; Satgunaseelan L; Asher R; Low H; Palme CE; Lee JH; Clark JR; Gupta R
J Surg Oncol; 2020 Dec; 122(8):1755-1760. PubMed ID: 32926758
[TBL] [Abstract] [Full Text] [Related]
4. Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study.
Bekaii-Saab TS; Ou FS; Ahn DH; Boland PM; Ciombor KK; Heying EN; Dockter TJ; Jacobs NL; Pasche BC; Cleary JM; Meyers JP; Desnoyers RJ; McCune JS; Pedersen K; Barzi A; Chiorean EG; Sloan J; Lacouture ME; Lenz HJ; Grothey A
Lancet Oncol; 2019 Aug; 20(8):1070-1082. PubMed ID: 31262657
[TBL] [Abstract] [Full Text] [Related]
5. Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Roncati L
Acta Dermatovenerol Croat; 2018 Dec; 26(4):341-343. PubMed ID: 30665488
[TBL] [Abstract] [Full Text] [Related]
6. Cutaneous Metastasis of Adenocarcinoma of the Ampulla of Vater.
Fernandez-Flores A; Cassarino DS
Am J Dermatopathol; 2018 Oct; 40(10):758-761. PubMed ID: 29672360
[TBL] [Abstract] [Full Text] [Related]
7. Sebaceous Carcinoma Treated With Mohs Micrographic Surgery.
Brady KL; Hurst EA
Dermatol Surg; 2017 Feb; 43(2):281-286. PubMed ID: 28165350
[TBL] [Abstract] [Full Text] [Related]
8. [Challenges for Urologists in the Care of Patients with Lynch Syndrome: Example of A Patient with Muir-Torre Syndrome, A Subtype of Lynch Syndrome].
Löhmann C; Kächele V; Martinschek A; Sparwasser C
Aktuelle Urol; 2016 Apr; 47(2):144-7. PubMed ID: 26509248
[TBL] [Abstract] [Full Text] [Related]
9. Resolution of Benign and Malignant Sebaceous Neoplasms, in a Renal Transplant Patient Treated With Everolimus.
Donati M; Paolino G; Muscardin L; Panetta C; Donati P
Exp Clin Transplant; 2017 Feb; 15(1):100-102. PubMed ID: 25924010
[TBL] [Abstract] [Full Text] [Related]
10. B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells.
Roos WP; Quiros S; Krumm A; Merz S; Switzeny OJ; Christmann M; Loquai C; Kaina B
Oncotarget; 2014 Dec; 5(24):12607-20. PubMed ID: 25557167
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD).
Wimmer K; Kratz CP; Vasen HF; Caron O; Colas C; Entz-Werle N; Gerdes AM; Goldberg Y; Ilencikova D; Muleris M; Duval A; Lavoine N; Ruiz-Ponte C; Slavc I; Burkhardt B; Brugieres L;
J Med Genet; 2014 Jun; 51(6):355-65. PubMed ID: 24737826
[TBL] [Abstract] [Full Text] [Related]
12. [Constitutional mismatch repair-deficiency syndrome (CMMR-D) - a case report of a family with biallelic msh6 mutation].
Ilenčíková D
Klin Onkol; 2012; 25 Suppl():S34-8. PubMed ID: 22920205
[TBL] [Abstract] [Full Text] [Related]
13. A phase II trial of intrapatient dose-escalated sorafenib in patients with metastatic renal cell carcinoma.
Amato R; Zhai J; Willis J; Saxena S; DeFoe M
Clin Genitourin Cancer; 2012 Sep; 10(3):153-8. PubMed ID: 22551785
[TBL] [Abstract] [Full Text] [Related]
14. 3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model.
Paulitschke V; Schicher N; Szekeres T; Jäger W; Elbling L; Riemer AB; Scheiner O; Trimurtulu G; Venkateswarlu S; Mikula M; Swoboda A; Fiebiger E; Gerner C; Pehamberger H; Kunstfeld R
J Invest Dermatol; 2010 Jun; 130(6):1668-79. PubMed ID: 19956188
[TBL] [Abstract] [Full Text] [Related]
15. Compound heterozygosity for msh6 mutations in a pediatric lymphoma patient.
Peters A; Born H; Ettinger R; Levonian P; Jedele KB
J Pediatr Hematol Oncol; 2009 Feb; 31(2):113-5. PubMed ID: 19194194
[TBL] [Abstract] [Full Text] [Related]
